Press Releases :: Nighthawk Biosciences, Inc. (SCPX)

Feb 06, 2024 8:00am EST

NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open Today

Feb 01, 2024 8:00am EST

NightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating Officer

Jan 30, 2024 8:00am EST

NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note

Jan 25, 2024 8:30am EST

NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program

Jan 16, 2024 8:30am EST

NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New Client

Jan 08, 2024 8:30am EST

NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMO

Jan 03, 2024 8:30am EST

NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National University

Dec 21, 2023 8:30am EST

NightHawk Biosciences Announces Completion of Demonstration Run for a Top-Tier NIH and DTRA Funded Research University

Dec 18, 2023 8:30am EST

NightHawk Biosciences Announces Major Milestone with Completion of Manufacturing Run for a Premier U.S.-Based Biopharmaceutical Company

Dec 12, 2023 8:30am EST

NightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core Assets

rss_feed News RSS